Learning to Debunk Phony Ad Claims

A large passenger transport organization in Britain issued a poster rejoicing over the reliability of its services The poster compared the number of occasions when passengers reached their destinations in accordance with the timetable with the number of delayed arrivals. “The red dots ran late,” said the headline. “The black dots ran on time.” And the message seemed clear enough. Black dots so greatly outnumbered the red ones that they appeared to occupy almost the whol

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A large passenger transport organization in Britain issued a poster rejoicing over the reliability of its services The poster compared the number of occasions when passengers reached their destinations in accordance with the timetable with the number of delayed arrivals. “The red dots ran late,” said the headline. “The black dots ran on time.” And the message seemed clear enough. Black dots so greatly outnumbered the red ones that they appeared to occupy almost the whole of the advertisement space. The counts of black and red dots were indeed proportional to the numbers of journeys completed on and off schedule. But the designer had squeezed the red dots closer together, down one side of the poster, so that they covered a disproportionately small area compared with the black dots. The actual record of unpunctuality was far worse than the impression gained at a glance.

This is just one example of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies